Adverse Drug Reactions
Safety Measures for Oseltamivir Phosphate and Chugai's Future Approach
Published in Mental Health Business Week, July 7th, 2007
Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; President Osamu Nagayama (hereafter, "Chugai")] announced today that on June 16, it has presented in "Sub-committee on Safety of Drug" of the Ministry of Health, Labour and Welfare, regarding Chugai's approach on the safety measures of anti-influenza drug "oseltamivir" (product name: Tamiflu), imported from F. Hoffmann-La Roche Ltd. ("Roche") [Head Office: Basel, Switzerland. CEO: Franz B. Humer] for production and marketing in Japan.
In the sub-committee, seven groups and members including Chugai, namely, Yakugai Tamiflu Higaisha no kai,iYAKUGAI Ombudsperson "Medwatcher Japan," Non Profit Organization Japan...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Addiction Medicine
Hazelden Report: Metro Area Methamphetamine Abuse Plummets, Reversing Previous Upward Trends - Addiction Medicine
pro adicta: Already More Than 1000 Successful Detoxifications From Opiate Addiction Thanks to Escape, a Treatment Method Using Neuroelectric Stimulation - Alcoholism Risk Factors
Findings from RAND Corporation broaden understanding of alcoholism risk factors - Alcoholism Risk Factors
Research on alcoholism risk factors detailed by scientists at National Development and Research Institutes, Inc. - Anxiety Therapy
Reports outline anxiety therapy study results from Cambridge Health Alliance - Attention Deficit Hyperactivity Disorder
Noven & Shire to Develop New Transdermal Patch for ADHD - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
